Swissnex in San Francisco and the Swiss Business Hub in San Francisco invite startups, corporates and researchers to join the discussion on the future of antibody therapies at the Festival of Biologics 2024 in San Diego.

This panel focuses on shedding light on new approaches in antibody therapies – building on the mAbs technology, often dubbed the “Swiss army knife” – and discussing manufacturing and purification challenges that result in high costs and long lead times.

The panel brings together Swiss and US expertise and also bridges the worlds of academia, startups, and the corporate side with speakers from those fields.

The panel is open to all conference attendees. As partners of the Festival of Biologics, Swissnex is able to offer free passes to the conference for pharma, biotech, academia, and regulators (excluding service and solution providers and consultants). Please get in touch with us if you’re interested.

The general conference program can be found here.